Skip to content

Lucid Diagnostics LUCD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-959.6%+185pp-1,054.8%+4.8pp-1,091.3%-13.9pp-1,099.5%+73.2pp-1,144.2%+363pp
Net margin-876.7%+605pp-1,232.7%-185pp-1,211.3%-141pp-1,267.4%-39.6pp-1,481.5%+95.1pp
EBITDA margin-942.6%+180pp-1,036.3%-3.5pp-1,071.2%-31.4pp-1,079.4%+41.2pp-1,123%+304pp
Returns
Return on assets-134.6%+56.1pp-163%-6.0pp-140.6%+19.9pp-151.8%-30.0pp-190.7%-74.8pp
Efficiency
Asset turnover0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×+0.1×
Liquidity
Current ratio1.1×+0.3×1.3×+0.2×1.9×+0.7×1.1×-0.6×0.8×-0.6×
Quick ratio1.1×+0.3×1.3×+0.2×1.9×+0.7×1.1×-0.6×0.7×-0.6×
Cash ratio0.9×+0.3×1.2×+0.3×1.8×+0.8×1.1×-0.5×0.7×-0.6×
Leverage
Debt-to-equity0.4×
Debt-to-assets0.0×0.0×-0.1×0.1×0.0×0.1×0.0×
Interest coverage-2,463.4×-387×-2,158.3×-387×-2,000.2×-496×-2,084.3×-1,834×-2,076×-1,962×
Valuation
Market capitalization$204.13M+58.5%$142.9M+194%$102.91M+162%$128.75M+249%$135.22M+294%
Enterprise value$177.85M+78.0%$110.01M+281%$57.65M+108%$99.9M+564%$112.49M+969%
Price / sales39.8×+10.2×30.4×+19.2×23.4×+14.0×29.5×+19.8×32.4×+20.9×
Price / book51×+34.7×
EV / sales34.6×+11.7×23.4×+16.7×13.1×+6.5×22.9×+19.0×27×+23.4×
Earnings yield-22.1%+20.9pp-40.6%+53.1pp-51.8%+62.3pp-42.9%+83.5pp-45.7%+91.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Lucid Diagnostics's profit margins?
Lucid Diagnostics (LUCD) runs a -66.8% gross margin and a -959.6% operating margin, with a -876.7% net margin.
Where do Lucid Diagnostics's ratios come from?
Every ratio is computed from Lucid Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.